Novo Holdings A/S Increases Stake in 4D Molecular Therapeutics, Inc.

Novo Holdings A/S, a Danish investment firm, has increased its stake in 4D Molecular Therapeutics, Inc. (FDMT) to 6.8% ownership, representing 3,175,000 shares. This marks a significant increase of 58.75% in shares and 321.05% in value compared to previous holdings. The filing, submitted on October 20, 2025, under Schedule 13G, indicates that Novo Holdings A/S has sole voting and dispositive power over these shares. The firm certifies that the shares were not acquired to influence the control of the issuer. This filing highlights a substantial investment by Novo Holdings A/S in the biotechnology sector.